Profile picture

Doctor Guiomar Mendieta Badimon

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)
Membership: FESC Member
Follow
Biography
Guiomar Mendieta MD PhD MSc FESC is currently a Clinical Cardiologist at the Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona. She obtained her MD from the Autonomous University of Barcelona, Spain (2014), and completed her residency in Cardiology at Hospital Clínic Barcelona (2015–2020). She conducted translational research in cardioprotection in ischaemic heart disease, earning her PhD in Medicine from the University of Barcelona in 2020. Previous appointments include physician-scientist at CNIC in Madrid (2020-2022), Clinical Cardiologist and Cardiac Imaging fellow at Hospital Clinic and Clinical Scientist at IDIBAPS Barcelona (2023-2024). She holds an MSc in Epidemiology (LSHTM, London, 2021) and a Postgraduate Course in Heart Failure certificate (European Heart Academy, ESC-HF), Zurich, 2022. She has published over 60 peer-reviewed articles and 6 book chapters.
Logo ESC

Contributor content

Inflammation and LDL cholesterol contribute independently to the progression of early human atherosclerotic plaque
Presentation
Inflammation and LDL cholesterol contribute independently to the progression of early human atherosclerotic plaque
Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis.
Presentation
Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis.
CMR analysis of the cardioprotective effects of chronic statin therapy prior to first STEMI: a propensity score analysis
Presentation
CMR analysis of the cardioprotective effects of chronic statin therapy prior to first STEMI: a propensity score analysis
Interatrial block: a prognostic factor for atrial fibrillation in cryptogenic stroke patients
Presentation
Interatrial block: a prognostic factor for atrial fibrillation in cryptogenic stroke patients
Intravenous administration of IV-STATIN CARDIOSHIELD during myocardial infarction renders higher cardioprotection than oral atorvastatin given shortly after reperfusion: a translational CMR study
Presentation
Intravenous administration of IV-STATIN CARDIOSHIELD during myocardial infarction renders higher cardioprotection than oral atorvastatin given shortly after reperfusion: a translational CMR study
Treating ischemic injury to reduce infarct size and achieve cardiac protection
Presentation
Treating ischemic injury to reduce infarct size and achieve cardiac protection
Interatrial block and reduced global left atrial strain are related to atrial fibrillation onset in patients with cryptogenic stroke
Presentation
Interatrial block and reduced global left atrial strain are related to atrial fibrillation onset in patients with cryptogenic stroke
Ticagrelor improves cardiac function and post-myocardial infarction healing: cardiac magnetic resonance imaging assessment of functional, anatomical and remodeling parameters.
Presentation
Ticagrelor improves cardiac function and post-myocardial infarction healing: cardiac magnetic resonance imaging assessment of functional, anatomical and remodeling parameters.
HDL and cardioprotection in the presence of cardiovascular risk factors. A cardiac magnetic resonance imaging-based study in a hypercholesterolemic pig model of ischemia/reperfusion.
Presentation
HDL and cardioprotection in the presence of cardiovascular risk factors. A cardiac magnetic resonance imaging-based study in a hypercholesterolemic pig model of ischemia/reperfusion.

ESC 365 is supported by